Found 8 matching trials
A Study Evaluating Mibavademab Treatment of Obesity Due to Leptin (LEP) Gene Mutations in Children, Adolescents and Adults PHASE3 This study is researching an experimental drug called mibavademab. The stud...
Show More Location
ULM University Medical Centre
Learn More & Join Trial
A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD) PHASE3 This study is researching an experimental drug called mibavademab. The stud...
Show More Location
National Institutes of Health
Learn More & Join Trial
Study of REGN4461, a Leptin Receptor Agonist Antibody, in Patients With Generalized Lipodystrophy PHASE2 The primary objectives of the study are to estimate the effects of REGN4461...
Show More Location
Regeneron Research Site
Learn More & Join Trial
A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity PHASE2 The main purpose of this study is to determine if combining tirzepatide wit...
Show More Location
Velocity Clinical Research, Gardena
Learn More & Join Trial
A Study to Examine the Effects of the Leptin Receptor (LEPR) Agonist Antibody REGN4461 in Adult Patients With Familial Partial Lipodystrophy (FPLD) PHASE2 Two cohorts are being studied based on leptin levels. Cohort A is composed ...
Show More Location
Excel Medical Clinical Trials - A Flourish Research Site
Learn More & Join Trial
Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy PHASE3 This study is researching a new drug called mibavademab (called "study drug...
Show More Location
University of Michigan
Learn More & Join Trial
A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea PHASE2 This study is researching an experimental drug called mibavademab (also cal...
Show More Location
Arensia Exploratory Medicine Clinic
Learn More & Join Trial
Expanded Access to REGN4461 for Patients With Diseases Associated With Deficient Leptin Signaling N/A Provide Expanded Access to REGN4461 for patients with diseases associated w...
Show More Location
Multiple Locations
Learn More & Join Trial